Reflections on Life in Romark

Discussion in 'Romark' started by anonymous, Jul 20, 2017 at 9:32 AM.

  1. anonymous

    anonymous Guest

    Romark is an interesting place, it has one product in 2 formulations since 2004. It is a private company so company books are not truly open. We believe what they tell us, or not. The patents are up and they have not moved ahead with any "new" product, just investigating a line extension which isn't working well. They have built out an organization with all the right functions but it is more like inviting everyone to a party and not serving any food or drink. People just busy themselves with very little new business to do, but are busy correcting years of mistakes and poor less than perfect management decisions. Sales are asked to sell a product for which there is no approved market so they sell off label and hide it. That's why the base salary is high because the sales are low. But if they are willing to pay a paycheck, then any port in the storm is welcome. I wonder how long the investors are willing to wait... oh, that's right they get dividends paid out from money collected from new unaware investors, so the story plays on. With all the high overhead, the clock is ticking.
     

  2. anonymous

    anonymous Guest

    It's amazing what abuse people will endure when people are afraid of losing their job.
     
  3. anonymous

    anonymous Guest

    Can you spell O-F-F L-A-B-E-L S-E-L-L-I-N-G.
     
  4. anonymous

    anonymous Guest

    When oh when will our management use their heads instead of their you know what? Maybe Irma will be the excuse they need to get out of the promises they have made.
     
  5. anonymous

    anonymous Guest

    I don't think they know their heads from their you know what. So promises mean nothing. Feel sorry for anyone who believes in this sham.
     
  6. anonymous

    anonymous Guest

    Tick, tock, tick, tock...wait for it.
     
  7. anonymous

    anonymous Guest

    How many million did the founder say they made selling Alina off label? Old Rossi is smoking dope encouraging off label sales telling employees the one off patent compound they have is effective in treating Lyme Disease and a dozen other infections. Oh did he mention it works for cancer too? Crazy. BTW - where have all the ethical employees gone? And when are the investors going to wake up? I suppose they seek investors that are not familiar with pharmaceuticals so they can pull the wool over their eyes. Marc Ayers is a slick one all right.
    Signed - One Investor who woke up too late
     
  8. anonymous

    anonymous Guest

    The previous poster is spot on.
     
  9. anonymous

    anonymous Guest

    No money? Who cares, let’s do some debit refinancing..... oh and keep hiring young people and firing people over 50. That way RMC can lower the average age of employees and save money on insurance. Now there’s someone you can trust, not! Age discrimination at its finest. What a toxic place to work. Where is FDA? Why aren’t they looking at the extreme off label practices of this organization? I guess FDA can’t collect enough money in fines to be worth the persuit.
     
  10. anonymous

    anonymous Guest

    Romark is a great small company. Their Alinia sales have gone through the roof over the last few years. They have a very solid plan going forward. Not sure why all the negativity out there. If you don’t like working at Romark, move on!!
     
  11. anonymous

    anonymous Guest

    Napoleon Rossignol has everyone buffaloed!! Crazy man looking to pad more Bentley’s and Rolls in his garage. Finally had everyone sign pharma guideline documents at last meeting. Sales are definitely off. Investors beware as well as employees promising to find the golden egg. It’s a rotten one!
     
  12. anonymous

    anonymous Guest

    Yes, buffaloed for sure.
     
  13. anonymous

    anonymous Guest

    The best ponzi scheme out there. Now that they took one of the covid loans from the government coupled with the new generic, the future looks grim. Investors beware!
     
  14. anonymous

    anonymous Guest

    I think the investors know they have a dud, but are hoping it miraculously gets something right. It doesn’t look good folks. A government loan for a COVID trial for which they aren’t paying the investigators has been sidelined to paying other bills. They haven’t paid their rent and are being evicted from the HQ offices at the Grand Hyatt in Tampa. And lastly, a generic has finally hit the market place for Romark’s only product.
     
  15. anonymous

    anonymous Guest

    They went through the roof because they quadrupled the price and sell off label, not because more doctors are prescribing it to more patients. Start looking for a new job.
     
  16. anonymous

    anonymous Guest

    I agree. Why did you take down the thread that included information regarding your salesperson that is living with one of your GI docs. Did you know about that? How many scripts have come from Cooper Health? Stop covering up. The whistle has already been blown in so many ways on Romark.
     
  17. anonymous

    anonymous Guest

    They also have missed their last 2 payrolls! Romark is such a wonderful place to work. Everyone can’t wait what bs MA will conjure up to keep everyone around for free until the company goes bankrupt!